251 related articles for article (PubMed ID: 18335793)
41. Correlation between intrasinusoidal neutrophilic infiltration and ceroid-lipofuscinosis in alcoholic liver fibrosis with or without fatty change: clinicopathological comparison with nutritional fatty liver.
Kishi M; Maeyama S; Koike J; Aida Y; Yoshida H; Uchikoshi T
Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):366A-370A. PubMed ID: 8986240
[TBL] [Abstract][Full Text] [Related]
42. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
Ali R; Cusi K
Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
[TBL] [Abstract][Full Text] [Related]
43. Nonalcoholic fatty liver disease in children: a single center experience.
A-Kader HH; Henderson J; Vanhoesen K; Ghishan F; Bhattacharyya A
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):799-802. PubMed ID: 18486560
[TBL] [Abstract][Full Text] [Related]
44. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors.
Jin YJ; Kim KM; Hwang S; Lee SG; Ha TY; Song GW; Jung DH; Kim KH; Yu E; Shim JH; Lim YS; Lee HC; Chung YH; Lee Y; Suh DJ
J Gastroenterol Hepatol; 2012 Aug; 27(8):1341-7. PubMed ID: 22554085
[TBL] [Abstract][Full Text] [Related]
45. Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies.
Turlin B; Ramm GA; Purdie DM; Lainé F; Perrin M; Deugnier Y; Macdonald GA
Liver Int; 2009 Apr; 29(4):530-5. PubMed ID: 19018987
[TBL] [Abstract][Full Text] [Related]
46. Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease.
Rakha EA; Adamson L; Bell E; Neal K; Ryder SD; Kaye PV; Aithal GP
J Clin Pathol; 2010 Sep; 63(9):790-5. PubMed ID: 20819880
[TBL] [Abstract][Full Text] [Related]
47. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.
Ekstedt M; Franzén LE; Mathiesen UL; Holmqvist M; Bodemar G; Kechagias S
J Hepatol; 2007 Jul; 47(1):135-41. PubMed ID: 17400325
[TBL] [Abstract][Full Text] [Related]
48. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
[TBL] [Abstract][Full Text] [Related]
49. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
50. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.
Brunt EM; Ramrakhiani S; Cordes BG; Neuschwander-Tetri BA; Janney CG; Bacon BR; Di Bisceglie AM
Mod Pathol; 2003 Jan; 16(1):49-56. PubMed ID: 12527713
[TBL] [Abstract][Full Text] [Related]
51. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure.
Canbay A; Bechmann LP; Best J; Jochum C; Treichel U; Gerken G
Z Gastroenterol; 2006 Mar; 44(3):245-8. PubMed ID: 16514570
[TBL] [Abstract][Full Text] [Related]
52. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
53. Correlation of steatosis with fibrosis and necro-inflammation in chronic hepatitis C infection in the absence of confounding factors.
Zubair A; Mubarik A; Jamal S; Arif A; Khan DA
J Coll Physicians Surg Pak; 2009 Jul; 19(7):417-20. PubMed ID: 19576148
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
Lee JY; Kim KM; Lee SG; Yu E; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Hepatol; 2007 Aug; 47(2):239-44. PubMed ID: 17400323
[TBL] [Abstract][Full Text] [Related]
55. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
56. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.
Choi SY; Kim D; Kim HJ; Kang JH; Chung SJ; Park MJ; Kim YS; Kim CH; Choi SH; Kim W; Kim YJ; Yoon JH; Lee HS; Cho SH; Sung MW; Oh BH
Am J Gastroenterol; 2009 Aug; 104(8):1953-60. PubMed ID: 19491838
[TBL] [Abstract][Full Text] [Related]
57. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P
J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862
[TBL] [Abstract][Full Text] [Related]
58. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.
Schwimmer JB
Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977
[TBL] [Abstract][Full Text] [Related]
59. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.
Mathurin P; Beuzin F; Louvet A; Carrié-Ganne N; Balian A; Trinchet JC; Dalsoglio D; Prevot S; Naveau S
Aliment Pharmacol Ther; 2007 May; 25(9):1047-54. PubMed ID: 17439505
[TBL] [Abstract][Full Text] [Related]
60. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
Duclos-Vallée JC; Yilmaz F; Johanet C; Roque-Afonso AM; Gigou M; Trichet C; Féray C; Ballot E; Dussaix E; Castaing D; Bismuth H; Samuel D; Guettier C
Clin Transplant; 2005 Oct; 19(5):591-9. PubMed ID: 16146549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
